P
Phio Pharmaceuticals Corp D
D
PHIO
2.47000
USD
0.05
(2.07%)
مغلق
حجم التداول
1,225
الربح لكل سهم
-2
العائد الربحي
-
P/E
-0
حجم السوق
11,851,440
الأخبار المقالات
العنوان: Phio Pharmaceuticals Corp
القطاع: Healthcare
الصناعة: Biotechnology
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.